Senior Advisor Subject Matter Expert (SME) with Pharmaceutical Development and Pain Expertise for the NINDS

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ASA OFFICE OF THE ASSISTANT SECRETARY FOR ADMINISTRATION

Contract Value

Not provided

Codes & Classification
Solicitation Number

7571PSQ00007

NAICS

541690 - Other Scientific and Technical Consulting Services

Classification Code

R499

Additional Details
Set Aside

SBA

Place of Performance

Bethesda, Maryland, UNITED STATES

SourceSAM
The Office of the Assistant Secretary for Administration (ASA), within the U.S. Department of Health and Human Services (HHS), has issued a combined synopsis/solicitation (Solicitation Number: 7571PSQ00007) seeking a Senior Advisor Subject Matter Expert (SME) with specialized expertise in pharmaceutical development and pain management. This procurement supports the National Institute of Neurological Disorders and Stroke (NINDS) as part of the NIH Helping to End Addiction Long-term (HEAL) Initiative, specifically within the Pain Therapeutics Development Program (PTDP). The HEAL Initiative is a high-priority, trans-agency effort aimed at accelerating scientific solutions to address the national opioid public health crisis. Purpose and Scope: The primary objective of this procurement is to secure the services of an executive-level Senior Advisor 2 with extensive experience in drug discovery and development, particularly in the fields of pharmacology and pain. The selected SME will provide expert feedback and technical guidance to NIH program leadership on drug discovery and development projects within the NINDS HEAL portfolio. Additionally, the SME will serve as a member of the HEAL External Oversight Committee, offering strategic direction on HEAL projects and, as needed, on other NIH drug discovery and development programs. Key Requirements and Deliverables: - The contractor must provide a highly qualified individual with a proven track record in pharmaceutical development and pain therapeutics. - The SME will be expected to deliver expert advice, participate in oversight committee activities, and contribute to the strategic guidance of HEAL and related NIH programs. - The role requires approximately 50 labor hours per year, with an option for up to an additional 50 hours annually, and may involve reimbursable travel (up to $2,000 per consultant per year, subject to prior approval). - All proposed key personnel must be employed by the contractor by the start of the contract period. - The contractor must submit resumes, letters of commitment, and a narrative demonstrating how proposed personnel meet the required qualifications. - Past performance examples relevant to similar federal or commercial projects must be provided. - Pricing must be submitted using the provided template, with clear rationale for any additional direct costs. Contract Structure and Terms: - The anticipated contract will be a fixed-price purchase order with a base period from November 5, 2026, to November 4, 2027, and two one-year option periods, not to exceed a total duration of three years. - The acquisition is set aside exclusively for small business concerns under NAICS code 541690 (Other Scientific and Technical Consulting Services), with a size standard of $19 million. - The place of performance is Bethesda, Maryland. - The contract incorporates standard FAR and HHSAR provisions and clauses, including requirements for key personnel, options for increased quantity, and options to extend the contract term. - Salary rates for individuals paid under this contract may not exceed the Executive Schedule, Level II, as defined by NIH policy. - All offerors must be registered and active in the System for Award Management (SAM) at the time of quote submission. Evaluation Criteria: Quotations will be evaluated based on technical capability (with a focus on personnel qualifications), price, and past performance. Offerors must provide clear and convincing evidence of their ability to fulfill the requirements, including detailed narratives and supporting documentation for key personnel and relevant experience. Submission Instructions and Contact Information: - Responses are due by 1:00 PM Eastern Time on November 2, 2026, and must reference Solicitation Number 7571PSQ00007. - All questions must be submitted by October 27, 2026, at 1:00 PM EST. - Submissions and inquiries should be directed to Michelle Cecilia, Contracting Officer, at [email protected] or 301-272-9118. - Additional details, including the Statement of Work and evaluation factors, are provided in the solicitation attachments available via the SAM.gov opportunity listing. This opportunity is well-suited for small businesses with demonstrated expertise in pharmaceutical development, pain therapeutics, and federal consulting, particularly those with experience supporting NIH or similar biomedical research initiatives. Contractors should ensure their proposed personnel meet the high standards of experience and leadership required for this strategic advisory role.
Documents10